Science ❯ Biotechnology

Cell Therapy

Research and Development T Cell Engineering Exosomes Gene-Modified Therapies Clinical Trials Immunotherapy Autoimmune Diseases Regenerative Medicine Pharmaceutical Research Stem Cell Research

Abeona Posts $8.7 Million Q1 From ZEVASKYN as Patient Treatments and Sites Expand

Early sales suggest the launch can grow without stretching the balance sheet.

Gilead Closes $7.8 Billion Arcellx Deal to Take Full Control of Anito‑cel

Butantan Strikes Deal to Make CAR-T in Brazil as New Case Points to Wider Uses

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Takeda Ends In-House Cell Therapy Research, Seeks Partners for Assets